Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas

Many renal cancer patients experience disease recurrence after combined treatments or immunotherapy due to permanence of cancer stem cells (CSCs). This study was conducted to evaluate the expression patterns and clinical significance of octamer-binding transcription factor 4 (OCT4) and NANOG as the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasti, Arezoo, Mehrazma, Mitra, Madjd, Zahra, Abolhasani, Maryam, Saeednejad Zanjani, Leili, Asgari, Mojgan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079110/
https://www.ncbi.nlm.nih.gov/pubmed/30082842
http://dx.doi.org/10.1038/s41598-018-30168-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079110/
https://www.ncbi.nlm.nih.gov/pubmed/30082842
http://dx.doi.org/10.1038/s41598-018-30168-4

Ejemplares similares